These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28643043)

  • 21. Feasibility evaluation of middle-phase
    Wu CH; Lu YH; Lee TH; Tu CY; Fuh JL; Wang YF; Yang BH
    Quant Imaging Med Surg; 2023 Aug; 13(8):4806-4815. PubMed ID: 37581034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Software development for quantitative analysis of brain amyloid PET.
    Matsuda H; Yamao T
    Brain Behav; 2022 Mar; 12(3):e2499. PubMed ID: 35134278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated cerebral blood flow proxy with increased beta-amyloid burden in Alzheimer's disease preclinical phase evaluated by dual-phase
    Kim GH; Kim BR; Yoon HJ; Jeong JH
    Sci Rep; 2024 Aug; 14(1):18480. PubMed ID: 39122860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI.
    Yamakuni R; Murakami T; Ukon N; Kakamu T; Toda W; Hattori K; Sekino H; Ishii S; Fukushima K; Matsuda H; Ugawa Y; Wakasugi N; Abe M; Ito H
    Ann Nucl Med; 2024 Oct; 38(10):835-846. PubMed ID: 38902587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data.
    Iaccarino L; La Joie R; Koeppe R; Siegel BA; Hillner BE; Gatsonis C; Whitmer RA; Carrillo MC; Apgar C; Camacho MR; Nosheny R; Rabinovici GD;
    Neuroimage; 2022 Feb; 246():118775. PubMed ID: 34890793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coupled Imaging with [
    Chiaravalloti A; Castellano AE; Ricci M; Barbagallo G; Sannino P; Ursini F; Karalis G; Schillaci O
    Mol Imaging Biol; 2018 Aug; 20(4):659-666. PubMed ID: 29404839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Reference Region to Measure Longitudinal Amyloid-β Change with
    Bullich S; Villemagne VL; Catafau AM; Jovalekic A; Koglin N; Rowe CC; De Santi S
    J Nucl Med; 2017 Aug; 58(8):1300-1306. PubMed ID: 28183994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation.
    Johns E; Vossler HA; Young CB; Carlson ML; Winer JR; Younes K; Park J; Rathmann-Bloch J; Smith V; Harrison TM; Landau S; Henderson V; Wagner A; Sha SJ; Zeineh M; Zaharchuk G; Poston KL; Davidzon GA; Mormino EC
    Alzheimers Dement; 2024 Aug; 20(8):5299-5310. PubMed ID: 38962867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A universal neocortical mask for Centiloid quantification.
    Bourgeat P; Doré V; Rowe CC; Benzinger T; Tosun D; Goyal MS; LaMontagne P; Jin L; Weiner MW; Masters CL; Fripp J; Villemagne VL; ;
    Alzheimers Dement (Amst); 2023; 15(3):e12457. PubMed ID: 37492802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
    Jang H; Park SB; Kim Y; Kim KW; Lee JI; Kim ST; Lee KH; Kang ES; Choe YS; Seo SW; Kim HJ; Kim YJ; Yoon CW; Na DL
    J Neurol; 2018 Jan; 265(1):63-73. PubMed ID: 29128930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early detection of amyloid load using
    Bullich S; Roé-Vellvé N; Marquié M; Landau SM; Barthel H; Villemagne VL; Sanabria Á; Tartari JP; Sotolongo-Grau O; Doré V; Koglin N; Müller A; Perrotin A; Jovalekic A; De Santi S; Tárraga L; Stephens AW; Rowe CC; Sabri O; Seibyl JP; Boada M
    Alzheimers Res Ther; 2021 Mar; 13(1):67. PubMed ID: 33773598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
    Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of simulated reduced injected dose on the assessment of amyloid PET scans.
    Young P; Heeman F; Axelsson J; Collij LE; Hitzel A; Sanaat A; Niñerola-Baizan A; Perissinotti A; Lubberink M; Frisoni GB; Zaidi H; Barkhof F; Farrar G; Baker S; Gispert JD; Garibotto V; Rieckmann A; Schöll M;
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):734-748. PubMed ID: 37897616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
    Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
    J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head-to-Head Comparison of 18F-Florbetaben and 18F-Flutemetamol in the Cortical and Striatal Regions.
    Cho SH; Choe YS; Kim YJ; Kim HJ; Jang H; Kim Y; Kim SE; Kim SJ; Kim JP; Jung YH; Kim BC; Lockhart SN; Farrar G; Na DL; Moon SH; Seo SW
    J Alzheimers Dis; 2020; 76(1):281-290. PubMed ID: 32474468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET.
    Son SH; Kang K; Ko PW; Lee HW; Lee SW; Ahn BC; Lee J; Yoon U; Jeong SY
    Clin Nucl Med; 2020 Jan; 45(1):e8-e14. PubMed ID: 31524679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriate reference region selection of
    Cho SH; Choe YS; Park S; Kim YJ; Kim HJ; Jang H; Kim SJ; Kim JP; Jung YH; Kim BC; Na DL; Moon SH; Seo SW
    Sci Rep; 2020 Sep; 10(1):14950. PubMed ID: 32917930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of in vivo
    Bucerius J; Barthel H; Tiepolt S; Werner P; Sluimer JC; Wildberger JE; Patt M; Hesse S; Gertz HJ; Biessen EAL; Mottaghy FM; Sabri O
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1119-1128. PubMed ID: 28321471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional patterns of 18F-florbetaben uptake in presenilin 1 mutation carriers.
    Sala-Llonch R; Falgàs N; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Perissinotti A; Pavía J; Campos F; Lladó A; Lomeña F; Sánchez-Valle R
    Neurobiol Aging; 2019 Sep; 81():1-8. PubMed ID: 31207465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
    Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
    J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.